These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

726 related articles for article (PubMed ID: 3042201)

  • 1. Cholesterol, lipoproteins, and coronary heart disease in women.
    Bush TL; Fried LP; Barrett-Connor E
    Clin Chem; 1988; 34(8B):B60-70. PubMed ID: 3042201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?
    LaRosa JC
    Womens Health Issues; 1992; 2(2):102-11; discussion 111-3. PubMed ID: 1617306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution of lipoproteins triglyceride and lipoprotein cholesterol in an adult population by age, sex, and hormone use- The Pacific Northwest Bell Telephone Company health survey.
    Wahl PW; Warnick GR; Albers JJ; Hoover JJ; Walden CE; Bergelin RO; Ogilvie JT; Hazzard WR; Knopp RH
    Atherosclerosis; 1981 Apr; 39(1):111-24. PubMed ID: 6941788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of oral contraceptive use with serum lipids and lipoproteins in young women: the Bogalusa Heart Study.
    Greenlund KJ; Webber LS; Srinivasan S; Wattigney W; Johnson C; Berenson GS
    Ann Epidemiol; 1997 Nov; 7(8):561-7. PubMed ID: 9408552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
    Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
    N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Women, lipoproteins and cardiovascular disease risk.
    LaRosa JC
    Can J Cardiol; 1990 May; 6 Suppl B():23B-29B. PubMed ID: 2188715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial infarction in women.
    Johansson S; Vedin A; Wilhelmsson C
    Epidemiol Rev; 1983; 5():67-95. PubMed ID: 6357823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins.
    Crook D; Godsland IF; Wynn V
    Am J Obstet Gynecol; 1988 Jun; 158(6 Pt 2):1612-20. PubMed ID: 3287933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction of alcohol consumption and oral contraceptive use on lipids and lipoproteins.
    Kruszon-Moran D; Burkman RT; Kimball AW; Bachorik PS; Gold EB
    Contraception; 1988 Jan; 37(1):39-51. PubMed ID: 3365983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
    Ettinger WH; Wahl PW; Kuller LH; Bush TL; Tracy RP; Manolio TA; Borhani NO; Wong ND; O'Leary DH
    Circulation; 1992 Sep; 86(3):858-69. PubMed ID: 1516198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for coronary heart disease in women.
    Hennekens CH
    Cardiol Clin; 1998 Feb; 16(1):1-8. PubMed ID: 9507775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a controlled exercise program on serum lipoprotein levels in women on oral contraceptives.
    Wynne TP; Frey MA; Laubach LL; Glueck CJ
    Metabolism; 1980 Dec; 29(12):1267-71. PubMed ID: 7453571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Women and ischemic cardiopathy].
    Assmann G; Davignon J; Fernández Cruz A; Gotto AM; Jacotot B; Lewis B; Paoletti R
    Rev Clin Esp; 1989 Oct; 185(6):308-15. PubMed ID: 2695994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high density lipoprotein cholesterol levels in Chinese healthy subjects and patients with certain diseases.
    Cai HJ; Li ZX; Yang SM
    Atherosclerosis; 1982 Jun; 43(2-3):197-207. PubMed ID: 7115460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum apolipoprotein A-I levels: relationship to lipoprotein lipid levels and selected demographic variables.
    Phillips NR; Havel RJ; Kane JP
    Am J Epidemiol; 1982 Aug; 116(2):302-13. PubMed ID: 6810694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Life-style correlates of risk factor change in young adults: an eight-year study of coronary heart disease risk factors in the Framingham offspring.
    Hubert HB; Eaker ED; Garrison RJ; Castelli WP
    Am J Epidemiol; 1987 May; 125(5):812-31. PubMed ID: 3565356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse influences of alcohol, tobacco, and oral contraceptive use on cardiovascular risk factors during transition to adulthood.
    Croft JB; Freedman DS; Cresanta JL; Srinivasan SR; Burke GL; Hunter SM; Webber LS; Smoak CG; Berenson GS
    Am J Epidemiol; 1987 Aug; 126(2):202-13. PubMed ID: 3605049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral contraceptives and cardiovascular risk. Taking a safe course of action.
    Derman RJ
    Postgrad Med; 1990 Sep; 88(4):119-22. PubMed ID: 2204902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.